| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/12/2002 | US20020127181 Antagonist diamidediphenolate compounds attached to a metal chelate and linking group; use as contrast agents for X-ray imaging and magnetic resonance imaging |
| 09/12/2002 | US20020127180 Reagents for the determination of cerebral regional acetylcholinesterase activity |
| 09/12/2002 | CA2743731A1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | CA2710031A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | CA2709871A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | CA2439579A1 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/11/2002 | EP1238978A2 Intermediates for the synthesis of radiolabelled tropanes |
| 09/11/2002 | EP1237584A1 Receptor binding conjugates |
| 09/11/2002 | CN1368972A Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the inhibitor |
| 09/10/2002 | US6448253 Adenosine A3 receptor modulators |
| 09/10/2002 | US6447748 Benzamide compounds for cancer imaging and therapy |
| 09/10/2002 | US6447747 Process for the preparation of radiopharmaceuticals |
| 09/10/2002 | US6447439 Device for conveying radioactive agents on angioplasty stents, respective method and kit |
| 09/06/2002 | WO2002068000A2 Polymeric imagable brachytherapy seed |
| 09/06/2002 | WO2002067999A2 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 09/06/2002 | WO2002067998A2 Devices and methods for the treatment of cancer |
| 09/06/2002 | WO2002067997A1 Manufacturing process to control particle size |
| 09/06/2002 | WO2002067859A2 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 09/06/2002 | WO2002067767A2 Methods and systems which use annexin for bioprofiling body lumen |
| 09/06/2002 | WO2002067761A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002005859A3 Radiotherapy |
| 09/06/2002 | WO2002002150A3 Stable radioiodine conjugates and methods for their synthesis |
| 09/06/2002 | WO2001091805A3 Compounds for targeting endothelial cells |
| 09/06/2002 | WO2001066156A3 Use of radiopharmaceuticals and intraoperative radiation probe |
| 09/06/2002 | WO2001018011A9 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | WO2001005439A9 Radiodetection and therapy of aberrant cell proliferation |
| 09/06/2002 | CA2753395A1 Novel bifunctional chelating compounds containing hydroxamic acid residues |
| 09/06/2002 | CA2438204A1 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 09/06/2002 | CA2438174A1 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 09/05/2002 | US20020122769 Buffering reagents, chelating agents and stabilizers |
| 09/05/2002 | US20020122768 Including a therapeutic radionuclide and an effective stabilizing amount of an aromatic stabilizer (e.g., a polyhydroxylated aromatic compound, an aromatic amine, or a hydroxylated aromatic amine) |
| 09/04/2002 | EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2002 | EP1235598A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 09/04/2002 | EP0748229B1 Polychelants |
| 09/04/2002 | CN1367023A Preparation method of biodegradable medicine composite macromolecular scaffold material |
| 09/03/2002 | CA2096841C Drug delivery porphyrin compositions and methods |
| 09/03/2002 | CA2079778C Inhibitors of thrombin |
| 09/03/2002 | CA2049089C Immunoassay reagents and method for determining cyclosporine |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066077A2 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066075A2 Biotin-derivatives and their conjugates with chelating agents |
| 08/29/2002 | WO2002024235A3 Prochelators of radiometal labeled molecules |
| 08/29/2002 | WO2001091808A3 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 08/29/2002 | WO2001091807A3 Ethylenedicysteine (ec)-drug conjugates |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001062301A3 Imaging agents for diagnosis of parkinson's disease |
| 08/29/2002 | WO2001061055A3 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
| 08/29/2002 | US20020119488 In vitro method for treating cancer; obtain stem cells, incubate with carriers specific for tumor cells, separate conjugate, purge blood cells and/or bone marrow |
| 08/29/2002 | US20020119473 Nucleotide sequence ligand for use in the detection diagnosis and treatment of cancer |
| 08/29/2002 | US20020119096 Fluorination of proteins and peptides for F-18 positron emission tomography |
| 08/29/2002 | US20020119095 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours |
| 08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
| 08/29/2002 | CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2436242A1 Biotin-derivatives and their conjugates with chelating agents |
| 08/28/2002 | EP1233968A2 Transition metal-cyclopentadienyl-tropane conjugates |
| 08/28/2002 | EP1233790A2 A33 antigen specific immunoglobulin products in cancer therapy |
| 08/28/2002 | EP1233752A2 Radiation sensitive liposomes |
| 08/28/2002 | EP1073609A4 Bismuth-213 generator and uses thereof |
| 08/28/2002 | EP0906129B1 Implantable medical device |
| 08/28/2002 | EP0868202B1 Cascade polymer complexes, process for producing the same and pharmaceuticals containing the same |
| 08/28/2002 | EP0828521B1 Sequestered imaging agents |
| 08/28/2002 | CN1089582C Agent for slow releasing medicine |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441025 Water soluble paclitaxel derivatives |
| 08/27/2002 | US6441017 Inhibitors of prenyl-protein transferase |
| 08/27/2002 | US6440996 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 08/27/2002 | US6440945 Enhancing blood perfusion ion by administering a dna encoding an angiogenic peptide; vascular endothelial growth factor (vegf) |
| 08/27/2002 | US6440487 Mixing solution of dehydrated phosphorus-32 enriched metaphosphoric acid with inert polymer to form emulsion, stabilizing, immersing transition metal stent in stabilized emulsion, removing, washing and drying radioactive stent |
| 08/27/2002 | US6440386 Stabilized radiophosphate-labeled proteins |
| 08/27/2002 | US6440058 Radioactive seeds and method for using same |
| 08/22/2002 | WO2002013875A3 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 08/22/2002 | WO2001089586A3 Tc and re carbonyl complexes for pertechnetate and perrhenate |
| 08/22/2002 | WO2001087354A3 Use of small molecule radioligands for diagnostic imaging |
| 08/22/2002 | US20020115717 Amyloid targeting imaging agents and uses thereof |
| 08/22/2002 | US20020114763 Inorganic materials for radioactive drug delivery |
| 08/21/2002 | EP1231944A2 Targeted delivery of therapeutic and diagnostic moieties |
| 08/21/2002 | EP1231942A1 Cobalamin conjugates useful as imaging agents and as antitumor agents |
| 08/20/2002 | US6437103 Radioimaging agents which exhibit high uptake and retention in the myocardium; radiolabeled fatty acid molecule is available or free of bonding and thus retains the transport and biochemical properties |
| 08/20/2002 | US6436365 Administration via catheter of radioactive metal complex to site of legion; treatment of athersclerosis; reduces undesired radioactive exposure of healthy tissue |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/15/2002 | WO2002062819A2 Backbone cyclized radiolabelled somatostatin analogs |
| 08/15/2002 | WO2002062810A2 Linkable sialyl lewis x analogs |
| 08/15/2002 | WO2002062780A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | WO2002062399A1 Gastric emptying |
| 08/15/2002 | WO2002062398A2 Radioactively labelled conjugates of phosphonates |
| 08/15/2002 | WO2002062397A2 Chelates of metals which can be activated by neutrons and their use for the measurement of labeled specimens |
| 08/15/2002 | WO2002044175A3 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 08/15/2002 | WO2001085221A3 Assessing levels of o6-alkylguanine-dna alkyltransferase in vivo |
| 08/15/2002 | US20020111486 Exhibits affinity for monoamine transporters useful in diagnosis of parkinson's disease |
| 08/15/2002 | US20020111303 Protein found in breast, prostate gland cells cancer membrane |
| 08/15/2002 | US20020111300 Methods for reduced renal uptake of protein conjugates |